TipRanks on MSN

Medexus Pharmaceuticals Reports Strong GRAFAPEX Performance Amidst Revenue Challenges

Medexus Pharmaceuticals Inc ( ($TSE:MDP) ) just unveiled an announcement. Medexus Pharmaceuticals reported its fiscal Q2 2026 results, ...

Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection

AM Eastern time on Thursday, November 13, 2025Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 12, 2025) - ...